Barentz Acquires the Trade Assets of Nutraceutical Distributor Biogredia
Hoofddorp, The Netherlands –July 3rd, 2023 – Barentz International, a leading global life science and performance materials ingredients distributor, has announced that it has acquired the trade assets of Biogredia, a distributor of premium, branded functional ingredients to the European nutritional supplement & sports nutrition markets. Operating from Sandefjord, Norway, Biogredia leverages a strong reputation in the nutraceuticals segment driven by its focus on partnering with high quality brand owners, a well-balanced product portfolio, combined with outstanding levels of service.
The acquisition of Biogredia follows the acquisition of the France based Natural Ingredients which Barentz acquired in December 2022 and will significantly strengthen Barentz’ value-added product offering of premium, branded nutraceutical ingredients. This aligns with Barentz’ strategy to further grow in the nutraceuticals markets globally.
Upon acquisition, Biogredia’s trade assets will be integrated in the Barentz EMEA operating structure with Biogredia’s trade name to continue to exist for a pre-defined period.
- Barentz acquires the trade assets of nutraceutical distributor Biogredia
- Biogredia’s business offers a unique and highly strategic opportunity to further strengthen and establish Barentz’ European nutraceutical business line in Northern-Europe, UK and Ireland
- Barentz will be able to instantly leverage Biogredia’s principal relationships across its strong European network
- Bengt Hansson, founder of Biogredia, will continue to play a key role in further growing the business post-completion of the acquisition by Barentz
Hidde van der Wal, CEO of Barentz, commented: “After the acquisition of Natural Ingredients last year, we started a separate business line for Nutraceuticals. Biogredia fits perfectly in the next step in our strategy. Bengt Hansson and his team believe in the same business principles as Barentz and together we will grow our position as a premium distributor in the important and attractive nutraceutical segment.”
Bengt Hansson, Founder of Biogredia added: “Our team indeed operates in line with the same business values as Barentz and their nutraceutical business approach for EMEA offers a lot of chances for further growth, together. Our Barentz portfolio will be impressive and strong. We are looking forward to entering this new era as part of Barentz, a great global company and strong brand.”
Established in 2015 and based in Sandefjord, Norway, Biogredia, through its wholly owned subsidiaries Biogredia Sweden and Biogredia UK, is engaged in the distribution and sales of branded functional ingredients to the European nutritional supplement & sports nutrition industry. For more information, visit https://biogredia.com/
Barentz is a leading global life science and specialty performance ingredients distributor. The company sources branded specialty ingredients from leading manufacturers worldwide and its ingredient experts provide value-added technical support which includes pre-mixing, blending, ingredient formulation and ingredient testing from its state-of-the-art, customized formulation centers and application laboratories in EMEA, Americas and Asia-Pacific.
Established in 1953, Barentz has operations in more than 70 countries with a strong presence in Europe and North America and a rapidly growing network in Latin America and Asia-Pacific. With a turnover of circa €2.5 billion, the company employs around 2,500 people worldwide and serves over 25,000 customers. For more information, visit: www.barentz.com.